T-LGL Leukemia Clinical Trials in Tianjin, Tianjin Municipality
4 recruitingTianjin, Tianjin Municipality, China
Showing 1–4 of 4 trials
Recruiting
Phase 2
Thalidomide for the Symptomatic Large Granular Lymphocytic Leukemia
T-LGL LeukemiaNK-LGL Leukemia
Institute of Hematology & Blood Diseases Hospital, China48 enrolled1 locationNCT06530576
Recruiting
Phase 2
JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas
Lymphoma, T-CellT-LGL LeukemiaNK-LGL Leukemia+7 more
Institute of Hematology & Blood Diseases Hospital, China48 enrolled2 locationsNCT06716658
Recruiting
Phase 2
PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas
Lymphoma, T-CellT-LGL LeukemiaNK-LGL Leukemia
Institute of Hematology & Blood Diseases Hospital, China51 enrolled1 locationNCT06530550
Recruiting
National Longitudinal Cohort of Hematological Diseases-Large Granular Lymphocytic Leukemia
T-LGL LeukemiaNK-LGL Leukemia
Institute of Hematology & Blood Diseases Hospital, China9,999 enrolled1 locationNCT07019766